ZEVRA THERAPEUTICS, INC. Quarterly Marketable Securities, Current in USD from Q4 2015 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Zevra Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2015 to Q1 2022.
  • Zevra Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2022 was $1.34M.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $1.34M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 Dec 31, 2021 10-Q 2022-05-12
Q4 2018 $3.26M -$28.1M -89.6% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $11.2M -$26.2M -70% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $11.7M -$29.4M -71.5% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $25.9M -$22.4M -46.4% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $31.4M -$19.6M -38.5% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $37.4M -$5.27M -12.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $41.1M -$14M -25.4% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $48.2M +$14.6M +43.3% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 $51M +$32M +168% Dec 31, 2016 10-K 2018-03-30
Q3 2016 $42.7M Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $55.1M Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $33.7M Mar 31, 2016 10-Q 2016-05-13
Q4 2015 $19M Dec 31, 2015 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.